Skip to content
‹ Back to IndustriesHealthcare

Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic. Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC. John Yianitsas, Vice President of New Business Development at Presco, said PVC…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic.

Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC.

John Yianitsas, Vice President of New Business Development at Presco, said PVC is a great fit when making PPE because it creates a tough-to-penetrate barrier, is easily cleanable, and can be either heat sealed or sewed. That gives users not only the opportunity to use PVC items more than once but also to utilize the material in a number of different ways.

“PVC can be used not only just for gowns, but drapes, barriers, and things like that, which is why I think it’s such a great product that can be used over and over again. It’s not a one-and-done,” Yianitsas said.

Few could say they saw a pandemic coming, so there was a rush to get PPE to those who needed it at the beginning of the pandemic. Luckily for those relying on Presco, the Texas-based company was able to turn around its products quickly since it was relying only on domestic materials and not waiting for supplies to arrive from abroad.

“I think the key factor in all this is the fact that we’re a domestic supplier. We source all our raw materials domestically, so we didn’t have to wait for anything to come in,” Yianitsas said. “Our ability to take an order and turn it around and fulfill it very, very quickly, the fact that we’re here in Sherman, Texas, gave us that opportunity to be able to respond very, very, quickly. Had we not had that capability, we would’ve been in the same boat as other people.”

Instead, Presco was able to help frontline workers in the United States do their job in a safe way, aiding the response when the country needed it most.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512